ArticleFrontiers in nutrition2024

Increased fat mass and obesity risk after elexacaftor-tezacaftor-ivacaftor therapy in young adults with cystic fibrosis.

Ana Merino Sánchez-Cañete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.